FDA OKs 50th & 51st anti-retroviral drugs

August 14, 2007

The U.S. Food and Drug Administration has tentatively approved nevirapine tablets and a pediatric medication used to treat the human immunodeficiency virus.

The FDA said the pediatric triple-fixed dose combination tablet of lamivudine, stavudine and nevirapine is the first fixed dose anti-HIV product designed to treat children under the age of 12 years.

The two drugs mark the 50th and 51st AIDS-related drugs approved or tentatively approved for purchase under the President's Emergency Plan for AIDS Relief.

The fixed dose combination comprises a complete HIV regimen taken twice daily and can also be dissolved in water for children who cannot swallow tablets. The FDA said the fact all three drugs are combined into one tablet that can be stored, distributed and administered easily is a significant advance in the treatment of children infected with HIV.

The FDA said its tentative approval means although existing patents or other factors prevent the sale of the products in the United States, the medications meets all U.S. manufacturing quality and clinical safety and efficacy requirements, helping ensure AIDS patients abroad can receive the same quality of medications as Americans.

Copyright 2007 by United Press International

Explore further: CAR T cell immunotherapy continues to yield complete responses in leukemia

Related Stories

Science panel urges rewrite of food allergy warning labels

November 30, 2016

"Made in the same factory as peanuts." ''May contain traces of tree nuts." A new report says the hodgepodge of warnings that a food might accidentally contain a troublesome ingredient is confusing to people with food allergies, ...

National trial to assess drugs for severe seizures

November 17, 2016

Questions remain regarding how best to treat patients experiencing prolonged, dangerous seizures. Although emergency medical teams around the country use a variety of approaches, more research is needed to give patients the ...

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.